Frequently Asked Questions
In 2022, the global Compounding Pharmacies Market is expected to be worth USD 13154.8 million.
The Compounding Pharmacies Market is estimated to increase at a CAGR of 5.50% between 2023 and 2030, reaching USD 20188.4 Million in 2030.
The sterility sector had the largest market share in 2022
The Compounding Pharmacies market is dominated by the Regulated Compounding sector
The Hospitals and Healthcare Facilities sector is the fastest growing in the Compounding Pharmacies market
North America held the most share (43.56%) in 2022
The top players include Galderma S.A., Allergan PLC, Merz Pharma, Laboratory ObvieLine, Bausch Health Companies Inc., La Roche-Posay, IMAGE SKINCARE, Glytone, Lasermed, SciVision Biotech Inc.
The primary drivers of the market are rising demand for tailored treatments, advancements in pharmaceutical compounding procedures, and the rising prevalence of chronic diseases.
The significant obstacles in the market are stringent regulatory requirements, limited insurance coverage for compounded drugs, and difficulties in maintaining quality control and uniformity.
The aging population, the expansion of compounded services in emerging nations, and Collaborations and collaborations with healthcare providers and pharmaceutical companies are the market’s most promising opportunities.